The effects of RGD (Arg-Gly-Asp) peptides on glaucoma filtration surgery in rabbits

Ophthalmic Surgery and Lasers

Volumn 29, Issue 4, 1998, Pages 309-317

  Avila, Marcel ^a   Ortiz, Gabriel ^a,b   Lozano, Jose M ^a   Franco, Pedro ^a   De Pérez, Gloria ^a   Patarroyo, Manuel E ^c  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^b Hospital San Juan de Dios   (Colombia)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; INTEGRIN;

ANIMAL TISSUE; ARTICLE; EXTRACELLULAR MATRIX; FILTRATION; GLAUCOMA; NONHUMAN; PRIORITY JOURNAL; RABBIT; SCAR FORMATION; TREATMENT INDICATION;

ANIMALS; CELL ADHESION; CILIARY BODY; CONJUNCTIVA; FEMALE; FIBROSIS; FILTERING SURGERY; FOLLOW-UP STUDIES; GLAUCOMA; OLIGOPEPTIDES; POSTOPERATIVE COMPLICATIONS; RABBITS; SCLERA;

EID: 0031901301     PISSN: 10823069     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Dueker D, Higginbotham E. Pharmacological modulation of filtration surgery wound healing. In: Higginbotham E, Lee D, eds. Management of Difficult Glaucoma. Boston: Blackwell; 1994:414-427.
2. Chen CW. Enhanced intraocular pressure controlling effectiveness of trabeculectomy by local application of mitomycin C. Trans Asia Pacific Acad Ophthalmol. 1983;9:172-184.
3. Chen CCW, Huang HT, Bair JS, et al. Trabeculectomy with simultaneous topical application of mitomycin C in refractory glaucoma. J Ocul Pharmacol. 1990;6:175-182.
4. Palmer SS. Mitomycin as adjunct chemotherapy with trabeculectomy. Ophthalmology. 1991;98:317-321.
5. Kitazawa Y, Kawase K, Matsuhita H, et al. Trabeculectomy with mitomycin: a comparative study with fluorouracil. Arch Ophthalmol. 1991; 109: 1693-1699.
6. Skuta GL, Beeson CC, Higginbotham EJ, et al. Intraoperative mitomycin versus postoperative 5-fluorouracil in high risk glaucoma filtering surgery. Ophthalmology. 1992;99:438-444.
7. Chabrer BA, Collings JM. Cancer Chemotherapy: Principles and Practice. Philadelphia: J. B. Lippincott; 1990:386-396.
8. Stamper RL, McMenemy MG, Lieberman MF. Hypotonus maculopathy after trabeculectomy with subconjunctival 5 F. U. Am J Ophthalmol. 1992; 114: 544-550.
9. Moster MR, Costa VP, Wilson RR, Schmidt CM. Complication of topical intraoperative subconjunctival mitomycin C in glaucoma filtration surgery. Invest Ophthalmol Vis Sci. 1993;34(Suppl):730.
10. Denick RJ, Pasquale L, Quigley H, Jampel H. Potential toxicity of mitomycin C. Arch Ophthalmol. 1991;109:1635-1643.
11. Hutchinson AK, Gressniklaus HE, Brown RH, et al. Clinicopathologic features of excised mitomycin filtering blebs. Arch Ophthalmol. 1994;112:74-80.
12. Nuys RM, Feiten PC, Pels E, et al. Histopathologic effects of mitomycin C after trabeculectomy in human glaucomatous eyes with persistent hypotony. Am J Ophthalmol. 1994,118:225-237.
13. Elner GS, Elner VM. The integrin superfamily and the eye. Invest Ophthalmol Vis Sic. 1996;37:696-701.
14. Cheresh DA. Integrins: structure, function and biological properties. Adv Mol Cell Biol. 1993;6:225-237.
15. Hershkovitz R, Melamed S, Greenspoon N, Lider O. Non peptidic analogues of the Arg-Gly-Asp (RGD) sequences specifically inhibit the adhesion of human Tenon's capsule fibroblasts to fibronectin. Invest Ophthalmol Vis Sci. 1994;35:2585-2591.
16. Yue BY. The extracellular matrix and its modulation in the trabecular meshwork. Surv Ophthalmol. 1996;40:379-388.
17. Craig WS, Cheng S, Mullen D, et al. Concept and progress in the development of RGD containing peptide. Pharmaceuticals Biopolymers. 1995;37:157-165.
18. Clark E, Brugge J. Integrins and signal transduction pathways: the road taken. Science. 1995;268:233-239.
19. Hynes RO. Integrins: versatility, modulation and signaling in cell adhesion. Cell. 1992;69:11-25.
20. Yang Ch. H, Huang TF, Liu KR, Chen M, Hung P. Inhibition of retinal pigment epithelial cell induced fractional retinal detachment by disintegrins: a group of arg-gly-asp containing peptides from viper venom. Invest Ophthalmol Vis Sci. 1996;37:843-854.
21. Choi ET, Engel L, Callow AD, et al. Inhibition of neointimal hyperplasia by blocking alpha V beta 3 integrin with a small peptide antagonist GpenGRGDSPCA. J Vasc Surg. 1994; 19:125.
22. Barany N, Merrifield RB. The Peptides: Analysis, Synthesis and Biology. New York: Academic Press; 1980.
23. Hougthen RA. General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proc Natl Acad Sci USA. 1985;82:5131-5135.
24. Rabowsky J, Dukes A, Lee DA, Leong K. The use of bioerodible polymers and daunorubicin in glaucoma filtration surgery. Ophthalmology. 1996; 103: 5:800-806.
25. Seetner A, Morin JD. Healing of trabeculectomies in rabbits. Can J Ophthalmol. 1979;14:121-125.
26. Xu Y, Yang G, Gin W, Chen K, Song X. Effect of subconjunctival daunorubicin on glaucoma surgery in rabbits. Ophthalmic Surg. 1993;24:382-388.
27. Balaji K, Gupta M, Moy J, Agarwala A, Edward D. The effects of verapamil on glaucoma filtration blebs in rabbits. Invest Ophthalmol Vis Sci. 1992;33(Suppl): 1392. Abstract.
28. Strauss G, Dunn E, Dunn R, Bodiford G, Christie J. Subconjunctival high dose plasminogen activator in rabbit filtration surgery. J Ocul Pharmacol. 1991; 7:9-19.
29. Skuta G, Parrish R. Wound healing in glaucoma filtering surgery. Surv Ophthalmol. 1987;32:149-170.
30. Mietz H, Diestelhorst M, Addicks K, Krieglstein G. Toxic changes in the ciliary epithelium after episcleral application of mitomycin C: an animal experimental study. Invest Ophthalmol Vis Sci. 1993;34(Suppl):997. Abstract.
31. Hyacinth LM, Jarrett TW, Gordon CS, et al. Inhibition of bladder tumor cell implantation in cauterized urothelium, without inhibition of healing by fibronectin-related peptide GRGDS. Ann Surg Oncol. 1995;2:450.
32. Steed DL, Ricotta J, Prendersgat J, et al. Promotion and acceleration of diabetic ulcer healing by RGD peptide matrix, RGD study group. Diabetes Care. 1995;1.